OMX Stockholm Pharmaceuticals a SX201030GI 指数
6982.66 SEK
{{ price }}
1.074984%
{{change_pct}}%
OMX Stockholm Pharmaceuticals a 价格走势图
过去24小时内的前5名涨幅最大者
| XBRANE.ST | Xbrane Biopharma AB (publ) | +9.33% | |
|---|---|---|---|
| ATORX.ST | Alligator Bioscience AB (publ) | +3.93% | |
| IBT-B.ST | Infant Bacterial Therapeutics AB (publ) | +3.89% | |
| BIOA-B.ST | BioArctic AB (publ) | +3.76% | |
| ACE.ST | Ascelia Pharma AB (publ) | +3.21% |
过去24小时内的前5名跌幅最大者
| VICO.ST | Vicore Pharma Holding AB (publ) | -5.97% | |
|---|---|---|---|
| MVIR.ST | Medivir AB (publ) | -3.05% | |
| ISOFOL.ST | Isofol Medical AB (publ) | -2.78% | |
| ACTI.ST | Active Biotech AB (publ) | -2.72% | |
| BINV.ST | BioInvent International AB (publ) | -2.56% |
OMX Stockholm Pharmaceuticals a SX201030GI 财务与交易概览
| OMX Stockholm Pharmaceuticals a指数价格 | 6982.66 SEK |
| 昨日收盘价 | N/A |
| 开盘价 | N/A |
| 买入价 | N/A x N/A |
| 卖出价 | N/A x N/A |
| 当日价格范围 | N/A |
| 52 周价格范围 | N/A |
| 成交量 | N/A |
| 平均成交量 | N/A |
交易信息
OMX Stockholm Pharmaceuticals a 指数价格历史
| 52 周最高 | N/A |
| 52 周最低 | N/A |
| 50 天移动平均线 | N/A |
| 200 天移动平均线 | N/A |
SX201030GI Index Statistics
| 平均成交量（3 个月） | N/A |
| 平均每日成交量（10 天） | N/A |
OMX Stockholm Pharmaceuticals a指数问答
什么是当前的SX201030GI指数价格？
OMX Stockholm Pharmaceuticals a SX201030GI指数今天的价格是6982.66 SEK。
如何购买OMX Stockholm Pharmaceuticals a指数？
您可以在Nasdaq GIDS交易所购买SX201030GI指数。请联系您的财务顾问以选择经纪商。
OMX Stockholm Pharmaceuticals a指数的股票代码是什么？
OMX Stockholm Pharmaceuticals a指数的股票代码是SX201030GI。
OMX Stockholm Pharmaceuticals a指数包含多少个成分？
OMX Stockholm Pharmaceuticals a指数包含32个成分。
OMX Stockholm Pharmaceuticals a指数属于哪个国家？
OMX Stockholm Pharmaceuticals a指数所属国家是United States。
OMX Stockholm Pharmaceuticals a指数属于哪个交易所？
OMX Stockholm Pharmaceuticals a指数所属交易所是Nasdaq GIDS。
OMX Stockholm Pharmaceuticals a 成分
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 |
|---|
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 |
|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
| Swedish Orphan Biovitrum AB (publ) SOBI.ST | $309 30.16 USD |
+0.46
|
$106.13B 10.36B USD | $49.9K 4.87K USD | $305 29.77 USD | $309.8 30.24 USD | $106.13B 10.36B USD | 27.01 | $11.44 1.12 USD |
| Camurus AB (publ) CAMX.ST | $534.5 52.17 USD |
-1.02
|
$31.47B 3.07B USD | $72.68K 7.09K USD | $533 52.03 USD | $552.5 53.93 USD | $31.47B 3.07B USD | 74.44 | $7.18 0.7 USD |
| Bonesupport Holding AB (publ) BONEX.ST | $278.6 27.19 USD |
-2.31
|
$18.35B 1.79B USD | $28.33K 2.76K USD | $277.8 27.12 USD | $283 27.62 USD | $18.35B 1.79B USD | 150.59 | $1.85 0.18 USD |
| BioArctic AB (publ) BIOA-B.ST | $181.9 17.76 USD |
+3.76
|
$16.1B 1.57B USD | $323.03K 31.53K USD | $177 17.28 USD | $186.6 18.21 USD | $16.1B 1.57B USD | 0 | -$2 -0.1 USD |
| Biotage AB (publ) BIOT.ST | $141.9 13.85 USD |
-0.07
|
$11.36B 1.11B USD | $196.17K 19.15K USD | $141.7 13.83 USD | $142.2 13.88 USD | $11.36B 1.11B USD | 44.62 | $3.18 0.31 USD |
| Calliditas Therapeutics AB (publ) CALTX.ST | $208 20.3 USD |
0
|
$11.24B 1.1B USD | $0 0 USD | $0 0 USD | $0 0 USD | $11.24B 1.1B USD | 0 | $0 0 USD |
| BioGaia AB (publ) BIOG-B.ST | $106.4 10.39 USD |
+0.66
|
$10.76B 1.05B USD | $137.75K 13.45K USD | $104.5 10.2 USD | $106.6 10.41 USD | $10.76B 1.05B USD | 34.88 | $3.05 0.3 USD |
| MedCap AB (publ) MCAP.ST | $445.5 43.49 USD |
-0.67
|
$6.67B 651.49M USD | $3.3K 322.51 USD | $444 43.34 USD | $448 43.73 USD | $6.67B 651.49M USD | 32.78 | $13.59 1.33 USD |
| Probi AB (publ) PROB.ST | $348 33.97 USD |
0
|
$3.97B 387.05M USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.97B 387.05M USD | 0 | $0 0 USD |
| BioInvent International AB (publ) BINV.ST | $30.5 2.98 USD |
-2.56
|
$2.01B 195.91M USD | $18.73K 1.83K USD | $30.4 2.97 USD | $31.3 3.06 USD | $2.01B 195.91M USD | 0 | -$7.12 -0.6 USD |
| Vicore Pharma Holding AB (publ) VICO.ST | $8.03 0.78 USD |
-5.97
|
$1.88B 183.87M USD | $223.1K 21.78K USD | $7.88 0.77 USD | $8.55 0.83 USD | $1.88B 183.87M USD | 0 | -$1.99 -0.1 USD |
| Hansa Biopharma AB (publ) HNSA.ST | $24 2.34 USD |
+0.42
|
$1.57B 153.7M USD | $57.32K 5.6K USD | $23.84 2.33 USD | $24.48 2.39 USD | $1.57B 153.7M USD | 0 | -$9.25 -0.9 USD |
| Egetis Therapeutics AB (publ) EGTX.ST | $3.35 0.33 USD |
+2.76
|
$1.2B 117.3M USD | $304.85K 29.76K USD | $3.3 0.32 USD | $3.38 0.33 USD | $1.2B 117.3M USD | 0 | -$1 -0.09 USD |
| Saniona AB (publ) SANION.ST | $8.31 0.81 USD |
-1.54
|
$1.13B 110.39M USD | $207.16K 20.22K USD | $8.28 0.81 USD | $8.47 0.83 USD | $1.13B 110.39M USD | 4.72 | $1.76 0.17 USD |
| Xspray Pharma AB (publ) XSPRAY.ST | $30.35 2.96 USD |
-2.1
|
$1.13B 110.02M USD | $7.77K 758.55 USD | $30 2.93 USD | $33.45 3.27 USD | $1.13B 110.02M USD | 0 | -$7.59 -0.7 USD |
| SynAct Pharma AB SYNACT.ST | $17.96 1.75 USD |
-2.39
|
$880.2M 85.92M USD | $228.18K 22.27K USD | $17.46 1.7 USD | $18.22 1.78 USD | $880.2M 85.92M USD | 0 | -$2.08 -0.2 USD |
| Infant Bacterial Therapeutics AB (publ) IBT-B.ST | $58.8 5.74 USD |
+3.89
|
$792.12M 77.32M USD | $6.43K 627.65 USD | $57 5.56 USD | $60 5.86 USD | $792.12M 77.32M USD | 0 | -$9.34 -0.9 USD |
| Abliva AB (publ) ABLI.ST | $0.44 0.04 USD |
0
|
$715.67M 69.86M USD | $0 0 USD | $0 0 USD | $0 0 USD | $715.67M 69.86M USD | 0 | $0 0 USD |
| Orexo AB (publ) ORX.ST | $13.74 1.34 USD |
-0.43
|
$474.1M 46.28M USD | $3.1K 302.4 USD | $13.6 1.33 USD | $13.98 1.36 USD | $474.1M 46.28M USD | 0 | -$6.09 -0.5 USD |
| Xbrane Biopharma AB (publ) XBRANE.ST | $0.28 0.03 USD |
+9.33
|
$427.17M 41.7M USD | $15.59M 1.52M USD | $0.26 0.03 USD | $0.28 0.03 USD | $427.17M 41.7M USD | 5.57 | $0.05 0.004 USD |
- {{ link.label }} {{link}}